Shin et al. also showed that DEX infusion during ovarian cancer surgery suppressed postoperative levels of serum TNF-α and cortisol, sped up the recovery of NK cell activity, and lowered the tumor burden after surgery in mouse models of ovarian cancer xenograft [94]. This evidence concerns the gene TNF and ovarian carcinoma.